PaxeraHealth announced that the University of Pennsylvania has selected its zero-coding authoring platform to assist in their development of new imaging AI algorithms. ARK’s offering of “Algorithms as a service” aim to help healthcare systems and academic and research centers to DIY (Do-It-Yourself) their own AI algorithms for all possible modalities, body parts, and anomalies.

May 27, 2022 — PaxeraHealth announced that the University of Pennsylvania has selected its zero-coding authoring platform to assist in their development of new imaging AI algorithms. ARK’s offering of “Algorithms as a service” aim to help healthcare systems and academic and research centers to DIY (Do-It-Yourself) their own AI algorithms for all possible modalities, body parts, and anomalies. UPenn’s ultrasound research lab – Department of Radiology will use the platform to elevate the research and development of their associated imaging laboratories and expedite production of their focused algorithms.

“PaxeraHealth is pleased to offer our zero-coding authoring tools to the help ultrasound research team at UPenn complete the development of their algorithms for the sake of future patients everywhere,” said Dr. Mohamed Shoura, CEO of PaxeraHealth. “We understand the frustrations that come with developing new imaging algorithms and aim to eliminate these with the ARK platform.”

“Aligning UPenn’s research and primary development with Paxera’s high-end tools will expedite our timeline significantly and allow these algorithms to go to market much sooner than estimated”, added Dr. Sandy Sehgal, Professor and Director of ultrasound research at UPenn.

“PaxeraHealth’s ARK platform will be a key element in completing the development of these important algorithms,” added Dr. Laith Sultan, physician scientist at UPenn.

The collaboration between UPenn and Paxera will focus on the development of imaging algorithms to detect liver cancer as well as COVID detection via lung ultrasound. ARK’s high-end modeling, annotation, and data curation tools will reduce development timeline and expedite clinical validation, allowing UPenn to complete and commercialize their new algorithms and make them accessible to PaxeraHealth’s worldwide user base.

For more information: www.paxerahealth.com

 


Related Content

News | Radiation Oncology

July 16, 2026 — Raidium has announced the U.S. launch of Raidium Read (R.Read), applying its AI-native imaging solution ...

Time July 16, 2026
arrow
Feature | Information Technology | Kyle Hardner

Artificial intelligence (AI) has enhanced diagnostic accuracy and improved triage in radiology. But far fewer tools ...

Time July 16, 2026
arrow
News | ACR

July 15, 2026 — The American College of Radiology (ACR) recently issued a statement praising the inclusion of the ...

Time July 16, 2026
arrow
News | Ultrasound Imaging

July 13, 2026 — Neal F. Kassell, MD, founder and chairman of the Focused Ultrasound Foundation, received the inaugural ...

Time July 13, 2026
arrow
News | Radiation Oncology

July 10, 2026 — A new study led by researchers at the Icahn School of Medicine at Mount Sinai found that although the ...

Time July 10, 2026
arrow
News | PACS

July 8, 2026 — Freeland Systems, a cloud PACS and clinical imaging software company, has launched its new customer ...

Time July 10, 2026
arrow
News | Ultrasound Imaging

July 7, 2026 — Longeviti Neuro Solutions has launched a new strategic initiative, ClearFit AI, a Brain Ultrasound ...

Time July 09, 2026
arrow
News | Prostate Cancer

July 8,2026 — CorePlus, Puerto Rico’s fully digital precision pathology and clinical laboratory, has announced the ...

Time July 08, 2026
arrow
News | Women's Health

July 1, 2026 — Despite declining birth rates worldwide, the complexity of pregnancy is increasing. Advanced maternal age ...

Time July 01, 2026
arrow
News | Information Technology

June 26, 2026 — Radin Health recently announced the successful deployment of its cloud-native platform at four ...

Time June 26, 2026
arrow
Subscribe Now